These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 439391)

  • 41. [Clinical efficacy of T-1982 (cefbuperazone) for infections of children].
    Kurashige T; Kitamura I; Ogura H; Wakiguchi H; Morita H; Kuramitsu M; Kuroiwa Y; Tone Y; Mino M
    Jpn J Antibiot; 1983 Apr; 36(4):877-80. PubMed ID: 6876377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical studies of cefoperazone in pediatric field (author's transl)].
    Aoyama R; Kuronuma T; Nagata K; Izumi Y
    Jpn J Antibiot; 1980 Aug; 33(8):799-802. PubMed ID: 6451727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical experience of therapeutic use of cefmetazole (cefmetazon) or bronchopneumonia (author's transl)].
    Murao M; Terai T; Kirisawa T; Kon H; Moriyama Y; Hattori T
    Jpn J Antibiot; 1981 Jun; 34(6):856-63. PubMed ID: 6945446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of moxalactam therapy.
    Venezio FR; Westenfelder GO; Cook FV; Williams JE; Carruthers M; Reisberg BE; Emmerman J; Phair JP
    J Antimicrob Chemother; 1982 Nov; 10(5):435-43. PubMed ID: 6217184
    [No Abstract]   [Full Text] [Related]  

  • 45. [Clinical examination of cefoperazone in pediatrics (author's transl)].
    Matsuda H; Yoshida T; Kagata N; Niino S
    Jpn J Antibiot; 1980 Sep; 33(9):935-40. PubMed ID: 6452543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics and clinical efficacy of moxalactam in biliary tract infections.
    Mueller O; Fabricius K; Krueger E; Rueckert U
    Rev Infect Dis; 1982; 4 Suppl():S688-91. PubMed ID: 6218584
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Experimental and clinical studies on 6059-S (author's transl)].
    Toyonaga Y; Sugita M; Kurosu Y; Kumagai K; Hori M; Takahashi T
    Jpn J Antibiot; 1981 May; 34(5):764-81. PubMed ID: 6457175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Results of application of cefoperazone to pediatric infections (author's transl)].
    Furukawa S; Okada T; Hirao F
    Jpn J Antibiot; 1980 Sep; 33(9):925-30. PubMed ID: 6452541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Studies on cefmetazole (author's transl)].
    Seiga K; Minakawa M; Ekawa J; Yamaji K; Sugiyama Y
    Jpn J Antibiot; 1979 Apr; 32(4):525-31. PubMed ID: 459082
    [No Abstract]   [Full Text] [Related]  

  • 50. [Clinical trial of cefmetazole for severe infection in patients with blood diseases].
    Morioka M; Sakurada K; Higuchi A; Kawamura K; Musashi M; Sasaki O; Fujimoto N; Okabe M; Imamura M; Takemori N; Tanaka E; Miyazaki T
    Jpn J Antibiot; 1982 Jul; 35(7):1686-9. PubMed ID: 6960197
    [No Abstract]   [Full Text] [Related]  

  • 51. [Septicemia and focal infection. Efficacy of moxalactam. Results of the cooperative study conducted in France].
    Carbon C
    Sem Hop; 1983 Jun; 59(26):1981-4. PubMed ID: 6310791
    [No Abstract]   [Full Text] [Related]  

  • 52. [Clinical evaluation of cefotetan in pediatrics].
    Meguro H; Ozawa S; Togo T; Kim B; Arimasu O; Yonezawa H; Fujii R
    Jpn J Antibiot; 1983 Jun; 36(6):1262-70. PubMed ID: 6581331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical experience with cefoperazone in the pediatric field (author's transl)].
    Okamoto T; Oohara K; Hirose M; Hosoda T
    Jpn J Antibiot; 1980 Sep; 33(9):916-24. PubMed ID: 6452540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical results of cefoperazone in pediatric infections (author's transl)].
    Miyao M; Kuroda Y; Tanaka H; Mizui M; Uyama Y; Yuasa Y
    Jpn J Antibiot; 1980 Sep; 33(9):931-4. PubMed ID: 6452542
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experience of treatment of purulent osteomyelitis with cefmetazole (author's transl)].
    Kawashima M; Tamura H
    Jpn J Antibiot; 1982 Mar; 35(3):840-4. PubMed ID: 6954291
    [No Abstract]   [Full Text] [Related]  

  • 56. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 57. [Fundamental and clinical studies in pediatric field on cefoperazone, a cephalosporin derivative having broad spectrum newly developed in Japan (author's transl)].
    Nakazawa S; Sato H; Niino K; Nakazawa S; Suzuki H; Iwasaki A; Chikaoka H; Oka S; Hirama Y; Narita A
    Jpn J Antibiot; 1980 Aug; 33(8):803-19. PubMed ID: 6451728
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fundamental and clinical evaluations of cefmetazole against dermal infections by S. aureus (author's transl)].
    Watanabe Y; Yokoyama M; Itoh K; Yamada K
    Jpn J Antibiot; 1982 Jan; 35(1):261-7. PubMed ID: 6951062
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Moxalactam versus gentamicin-clindamycin in surgical sepsis. Efficacy and safety.
    Stone HH; Kolb L; Geheber CE
    Schweiz Rundsch Med Prax; 1983 Mar; 72(11):351-5. PubMed ID: 6221242
    [No Abstract]   [Full Text] [Related]  

  • 60. [Experience with cefmetazole in the urological fields].
    Tajima A; Ohmi Y; Masuda H; Ushiyama T; Fujii K; Hata M; Ohta N; Suzuki K; Fujita K; Aso Y
    Jpn J Antibiot; 1982 Aug; 35(8):1961-6. PubMed ID: 6961241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.